J06BD01 Palivizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Palivizumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J06 Immune sera and immunoglobulins 46 drugs
- J06B Immunoglobulins 45 drugs
- J06BD01 Palivizumab 2 drugs
- J06B Immunoglobulins 45 drugs
- J06 Immune sera and immunoglobulins 46 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Synagis (Abbvie) | prescription (Rx) |
| Synagis (Astrazeneca Canada) | prescription (Rx) |
Other classes of the same level
- J06BD03 Tixagevimab and cilgavimab 1 drug
- J06BD05 Sotrovimab 1 drug
- J06BD07 Casirivimab and imdevimab 1 drug
- J06BD08 Nirsevimab 1 drug
- J06BD09 Sipavibart 1 drug
- J06BD10 Clesrovimab 1 drug
Other names of the drug class
- Italian: J06BD01 PALIVIZUMAB
- German (Switzerland): J06BD01 Palivizumab
- French (Switzerland): J06BD01 Palivizumab
- Italian (Switzerland): J06BD01 Palivizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J06BD01
Ask your doctor or pharmacist for advice.